Press Releases

July 23, 2019

New Publication Compares Remote Electrical Neuromodulation for Acute Treatment of Migraine to Treatment with Acute Medications

Headache Researchers in California and Missouri Conducted a Per-Patient Comparison of FDA-Cleared Wearable Device with Contemporary Usual Care
Read More
June 24, 2019

Theranica Appoints Senior Executives to Lead its New USA Subsidiary

New Executive Team Will Oversee US Commercialization of FDA-Cleared Nerivio™ for Acute Treatment of Migraine
Read More
May 28, 2019

FDA Grants Theranica De Novo to Market First Smartphone-Controlled Acute Migraine-Relief Wearable Device

Clinical Data Show 66.7% Pain Relief Response Within Two Hours
Read More
May 13, 2019

OMRON VENTURES Joins Theranica’s Series B Funding Round as Strategic Investor

Strategic investment signals positive response of healthcare community to Theranica’s new approach to migraine management
Read More
March 18, 2019

Theranica Raises $35M to Bring Innovative Migraine Device to the USA aMoon leads round B of financing of the Israel-based company

aMoon leads round B of financing of the Israel-based company
Read More
November 15, 2018

Theranica Announces Results from Pivotal Study of Device for Treating Acute Migraine

Results of largest study with a migraine device solidify safety, efficacy and tolerability of the drug-free Nerivio Migra, offering huge clinical benefit for migraineurs
Read More
July 03, 2017

Theranica Raises $6M to Combat Migraine

Lightspeed leads round A of financing in Israel-based advanced e-health company
Read More